A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials
Authors:
- C DonnellanCDC Donnellan
- C PrestonCPC Preston
- B DelaneyBDB Delaney
- G DuckettGDG Duckett
- P MoayyediPMP Moayyedi
Abstract
Symptoms are an important outcome for measurement in clinical trials into gastro-oesophageal reflux disease, but the optimal approach to symptom assessment has not been formally evaluated. The authors conducted a systematic review to assess how reflux symptoms have been evaluated and how well these correlate with oesophagitis healing and relapse.Keywords
This publication has 140 references indexed in Scilit:
- A comparison of lansoprazole and ranitidine in the treatment of erosive oesophagitisAlimentary Pharmacology & Therapeutics, 1995
- Randomized, placebo‐controlled comparison of famotidine 20 mg b.d. or 40 mg b.d. in patients with erosive oesophagitisAlimentary Pharmacology & Therapeutics, 1994
- Efficacy of famotidine 20 mg twice a day versus 40 mg twice a day in the treatment of erosive or ulcerative reflux esophagitisDigestive Diseases and Sciences, 1993
- Effect of cisapride on relapse of esophagitisDigestive Diseases and Sciences, 1993
- Combination Therapy of Sucralfate and Ranitidine, Compared with Sucralfate Monotherapy, in Patients with Peptic Reflux EsophagitisScandinavian Journal of Gastroenterology, 1992
- Healing and prevention of relapse of reflux oesophagitis by cisapride.Gut, 1991
- Cimetidine 800 mg Twice Daily for Healing Erosions and Ulcers in Gastroesophageal Reflux DiseaseJournal of Clinical Gastroenterology, 1990
- Combined therapy with cisapride and cimetidine in severe reflux oesophagitis: a double blind controlled trial.Gut, 1988
- Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitisDigestive Diseases and Sciences, 1988
- Ranitidine in Reflux OesophagitisDigestion, 1984